Pinocembrin as a novel anti-cancer agent: Exploring preclinical evidence along with therapeutic potential.

World J Exp Med · 2025 · PMC12767260 · PMID 41497679

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

This synergy was confirmed through two-way analysis of variance and multiple t -tests, which showed highly significant interactions ( P < 0.0001)[ 33 , 48 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.